Zai Lab ZLAB
NASDAQ ZLAB
$26.23 -0.77 (-2.85%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zai Lab (ZLAB) Amortization of Deferred Charges (2024 - 2025)

Zai Lab (ZLAB) posted Amortization of Deferred Charges of -$1.4 million for Q1 2026, down 3.26% sequentially from -$1.3 million in Q4 2025, and down 4.66% YoY from -$1.5 million in Q1 2025.

Analysis

Zai Lab (ZLAB) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends

Zai Lab has reported Amortization of Deferred Charges for 9 years, with the latest figure at -$1.4 million in Q1 2026.

  • Quarterly Amortization of Deferred Charges fell 4.66% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (down 34.68% YoY) and the FY2025 annual result came in at -$5.3 million, down 51.7% from the prior year.
  • Amortization of Deferred Charges retreated to -$1.4 million in Q1 2026 per ZLAB's latest filing, from -$1.3 million in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at -$561000.0 in Q4 2022 and troughed at -$1.4 million in Q1 2026.
  • A 5-year average of -$955176.5 and a median of -$839000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
  • The sharpest annual moves came in 2022 and 2024: Amortization of Deferred Charges slumped 807.69% in 2022, then climbed 26.01% in 2024.
  • Over 5 years, Amortization of Deferred Charges stood at -$561000.0 in 2022, then slumped by 49.02% to -$836000.0 in 2023, then fell by 19.86% to -$1.0 million in 2024, then sank by 34.63% to -$1.3 million in 2025, then retreated by 3.26% to -$1.4 million in 2026.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods registered -$1.4 million, -$1.3 million, and -$1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Zai Lab 2.94 Bn 2.23 Bn 58.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 90,000.00
Jun 30, 2025 104,000.00
Mar 31, 2024 700,000.00